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ABSTRACT
Objective: To study the protective role of fruit extract of Anacardium occidentale (cashew apple) in aluminum-induced cognitive dysfunction and 
oxidative damage in albino rat, and to explore the neuroprotective effect of A. occidentale represented by behavior and memory tests.
Methods: Male Wistar rats (30) were divided into 5 groups of 6 rats each. Group I received normal saline. Group II was administered orally with 
aluminum chloride (100 mg/kg). Group III received rivastigmine 0.3 mg/kg body orally. Groups IV and V were administered with A. occidentale 
200 and 400 mg/kg along with aluminum chloride of 100 mg/kg orally after 1 hr interval. The study was carried out for 42 days (6 weeks). The 
behavioral assessment was performed using Rota-rod apparatus and Elevated plus maze and Biochemical parameters from brain homogenate such as 
acetylcholinesterase activity, total protein, lipid peroxidation malondialdehyde, superoxide dismutase (SOD), catalase, and glutathione reductase (GR) 
were estimated. All the data were analyzed using one-way analysis of variance followed by Tukey’s multiple comparison test.
Results: The % reduction of acetylcholinesterase, GR observed in A.O (400 mg/kg) dose as compared with that of standard drug was found to be 
87.5% and 89%, respectively, whereas % reduction of catalase and SOD observed in A.O (400 mg/kg) dose as compared with that of standard drug 
was found to be 97% and 99%, respectively.
Conclusion: This study demonstrates A. occidentale fruit has a neuroprotective effect against aluminum-induced behavioral changes.
Keywords: Occidentale, Neuroprotective, Alzheimer’s disease, Aluminum.
INTRODUCTION
Alzheimer’s is a degenerative and terminal disease for which there is 
no known cure. In its most common form it effects individuals over 
65 years old. Currently, there is no cure for Alzheimer’s and no way to 
stop the underlying death of brain cells. However, drugs and non-drug 
treatments may help with both cognitive and behavioral symptoms. 
Today, Alzheimer’s is at the forefront of biomedical research, with 
90% of what we know discovered in the past 20 years [1]. Some of 
the most remarkable progress has shed light on how Alzheimer’s 
disease affects the brain. A better understanding of its impact may lead 
to better ways to treat it. A comprehensive care plan for Alzheimer’s 
disease [2] involves monitoring treatment effectiveness as the disease 
progresses, changing course, and exploring alternatives as necessary 
and respecting individual and family goals for treatment and tolerance 
for risk.
The Anacardium occidentale has been reported to have immense 
pharmacological and therapeutic activity. Various research works 
carried out have proved it to be used in various diseases such as 
dermatitis, hyperglycemia, antiviral, and anti-inflammatory activity. The 
fruit juice and tea of the bark are very common diarrhea remedies [3]. 
The observed anti-inflammatory and anti-diarrheal activities of cashew 
extracts have been attributed to tannins [4].
Aluminum is a non-redox active metal which is capable of increasing the 
cellular oxidative milieu [5] by potentiating the pro-oxidant properties 
of transition metals such as iron and copper [6]. It leads to progressive 
deterioration of mitochondrial function which culminates into excessive 
free radical generation eventually resulting in DNA damage, nitration 
of protein residues, and lipid peroxidation. A. occidentale indicated 
significant cytoprotective effects against glutamate-triggered cell death 
in HT22 cells. Based on this background, this study was designed to 
investigate the neuroprotective effect [7] of A. occidentale against 




The cashew apple fruit species A. occidentale (700 g) was collected 
from Jangareddygudem, in Andhra Pradesh, India. The sample was then 
shade dried till constant weight obtained. The fruit of A. occidentale 
was identified and authenticated by Professor Dr. Vatsavaya S. Raju, 
M.Sc., Ph.D., D.A.S., FBS, FIAT, and the sample was deposited in the 
Herbarium, Department of Botany, Kakatiya University, Warangal, A.P., 
with specimen voucher number 1887. The species is known as “Jeedi 
Mamidi” locally and globally as “cashew nut.”
Chemicals
Aluminum chloride (CDH, India), rivastigmine (Novartis Co, Cairo, 
Egypt), ethanol 90%, acetylthiocholine iodide, DTNB reagent, Tris 
buffer, biuret reagent, trichloroacetic acid, potassium phosphate 
buffer, O-dianisidine solution, potassium dihydrogen and dipotassium 
hydrogen phosphate, Sodium phosphate buffer, xylene, hematoxylin, 
Eosin stain.
Animals
Healthy adult male albino rats of Wistar strain weighing (200-230 g) 
were chosen from the albino research training institute, Hyderabad, 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i3.15937
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India and were used for the experimental purpose. The animals 
were acclimatized to the standard laboratory conditions with 
temperature (25±2°C) and fed with standard animal pellet feed 
(Hindustan lever limited), ad libitum. The protocol was approved 
by the Institutional Animal Ethics Committee (IAEC) constituted for 
the purpose of animal experimentation as per CPCSEA guidelines 
(Reg. No. ARTI/CPCSEA/0034-2013), with approval no: (CPCSEA/IAEC/
EXP/25/50/2013/EXP-34) for the care and use of animals.
Extraction of plant material
The fruits (5-6 kg) were cleaned, and the size was reduced by cutting 
into small parts and were shade dried. They were coarsely powdered 
with the help of a blender (300 g). The coarse powder (250 g) of the 
fruits was then exhaustively extracted with 500 mL of ethyl alcohol 
using a soxhlet apparatus. The extract was concentrated by distilling 
the solvent and preserved under refrigeration for further studies. The 
obtained dried extract was further subjected to various chemical tests 
to detect the presence of different phytoconstituents [9].
Acute toxicity study
As per the OECD guidelines 423, the acute toxicity [10] of the alcoholic 
extract of A. occidentale was tested on different groups of 10 mice. 
Each receiving different doses of 50, 100, 200, 400, 800, 1000, and 
2000 mg/kg body weight. The number of deaths and behavioral 
changes were observed in each group and recorded within 48 hrs. Up 
to 2000 mg/kg, there were no signs of toxicity and mortality. Based on 
these studies, 200 and 400 mg/kg of A. occidentale were chosen for the 
present experimental study.
Allotment of animals and drug treatment
Male Wistar rats (30) were divided into 5 groups of 6 rats each by the 
computerized randomization method.
Group I served as normal control and received normal saline. Group II was 
administered with aluminum chloride at a dose of 100 mg/kg through 
oral route by dissolving in normal saline. Group III was administered 
with standard drug rivastigmine orally by dissolving in normal saline 
at a dose of 0.3 mg/kg. Groups IV and V were administered with test 
drug A. occidentale 200 and 400 mg/kg along with aluminum chloride 
at 100 mg/kg bodyweight through the oral route. The study was carried 
out for 42 days (6 weeks). The drug was administered orally 1 h after 
aluminum chloride administration.
Behavioral assessment
On the day 0, 21, 42 behavioral assessment was carried out for Elevated 
plus Maze and Rota-rod apparatus.
Muscle relaxant property by using rota-rod method
Turn on the Rota-rod by selecting an appropriate speed (20-25 rpm). 
Place the animal one by one into several compartments. Note down the 
“fall off time” when the rat falls from the Rotating rod. A normal group 
of rats generally falls off within 3-5 minutes. Later the treated groups 
are followed by noting the fall off time.
Fig. 1: Performance using elevated plus Maze
Fig. 2: Effect of muscle relaxant property by using Rota rod 
method
Fig. 3: Estimation of acetyl cholinesterase activity
Fig. 4: Estimation of total protein
Table 1: Performance using elevated plus Maze
Groups Treatment Initial transfer latency Transfer latency 1st trial (21st day) Transfer latency 2nd trial (42nd day)
Group I Vehicle only 61.90±0.55 18.02±0.22 16.02±0.44
Group II Alcl3 (100 mg/kg) 66.13±1.04 79.98±1.11* 74.98±0.92*
Group III Rivastigmine (0.3 mg/kg) 64.00±0.63 19.48±0.41$ 16.05±0.47$
Group IV A.O (200 mg/kg) 66.73±0.61 47.34±1.32$a 42.84±1.02$a
Group V A.O (400 mg/kg) 67.12±0.77 32.59±0.60$ 27.09±1.79$
Values were expressed as mean±SEM of each group (n=6) and were significant when done One-way ANOVA with Tukey’s post hoc test. *p<0.001 when compared with 
normal, $p<0.001 with positive control, ap<0.001 with the standard, SEM: Standard error mean
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Performance on elevated plusMaze
The elevated plus maze consisted of two opposite black open arms 
(50×10 cm), crossed with two closed walls of the same dimensions 
with 40 cm high walls. The arms were connected to a central 
square of dimensions 10×10 cm the entire maze was placed 50 cm 
high above the ground. Acquisition of memory was tested on day 
20 from the start of aluminum chloride administration. Rats were 
placed individually at one end of the open arm facing away from the 
central square. The time taken by the animal to move from the open 
arm to the closed arm was recorded as the initial transfer latency 
(ITL). Retention of memory was assessed by placing the rat in an 
open arm and the retention latency was noted on day 21 and day 42, 
respectively.
Biochemical assessment
Biochemical tests were conducted 24 hrs after the last behavioral 
test. The animals were sacrificed by decapitation; the brains were 
removed, weighed and kept on ice. A 10 % (w/v) tissue homogenate 
was prepared in 0.1 M phosphate buffer (pH 7.4) using Teflon tissue 
homogenizer at 1000 × g for 20 minutes at 4°C. The homogenate so 
obtained was used for the assessment of biochemical parameters [11] 
such as acetylcholinesterase (AchE) [12], protein, lipid peroxidation 
malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and 
glutathione reductase (GR) activities.
Histopathological examination
The whole brain of the rat was taken and divided into two sections; 
the first portion was used for biochemical estimation and the second 
portion of the brain was fixed in formalin buffer (10%) for 24 hrs. 
The brains are washed in tap water and then dehydrated using serial 
dilutions of alcohol. Specimens are cleared in xylene and embedded in 
paraffin in a hot air oven at 56°C for 24 hrs. Paraffin beeswax blocks 
are prepared for sectioning at 4 mm using a microtome. The obtained 
tissue sections are collected on glass slide deparaffinized, stained with 
hematoxylin and eosin stains for histopathological examination using a 
light microscope.
Statistical analysis
All the data were expressed as mean±standard error mean (SEM) and 
were analyzed by One-way Analysis of variance (ANOVA) followed 
by Tukey’s multiple comparison test as a post hoc test. The value of 
p<0.001 was considered statistically significant. Data were analyzed 
using Graph Pad prism software.
RESULTS
For elevated plus maze method
In the elevated plus maze, on the 20th day the initial transfer latency 
(ITL) was taken and there was no significant variation. Normal control 
(*p<0.001) and Anacardium occidentale extract treated (200 mg/kg) 
and (400 mg/kg) rats entered closed arm quickly and the mean retention 
latencies (1st RTL &2nd RTL) to enter the closed arms on day 21 and 
42 were shorter when compared to ITL. Aluminium chloride treated 
($p<0.001) rats showed no variation in mean retention latency on 21st 
and 42nd day when compared to pretrained animals ITL on 20th day. This 
shows cognitive impairment of aluminium chloride treated animals. 
The results were observed and showed in the Table 1 and Figure 2.
For rota-rod method
In rota rod apparatus the fall off time is been recorded for each group 
of animal and is known to observe on 20th day as initial fall off time. 
Results provided in the Table 2 and Figure 2 reveals that the standard 
(ap<0.001), A. occidentale extract (200 mg/kg) & (400 mg/kg) showed 
decrease in fall off time on the 21st day and 42nd day after training. 
Positive control ($p<0.001) showed an increase in fall of time when 
compared to initial fall off time. This shows neurological deficit elicits 
motor in co-ordination.
For AchE activity
The % reduction of acetylcholinesterase observed in A.O (400 mg/kg) 
dose as compared with that of the standard drug was found to be 87.5% 
which was inferred from the Table 3 and Figure 3.
For estimation of total protein
Table 4 and Figure 4 reveals the % reduction of total protein observed 
in A.O (400 mg/kg) dose as compared with that of the standard drug 
was found to be 95%.
Table 2: Effect of muscle relaxant property by using rota rod 
method
Groups Treatment 1st trial  
(21st day)
2nd trial  
(42nd day)
Group I Vehicle only 167.3±2.17 142.7±5.10
Group II Alcl3 (100 mg/kg) 93.57±0.70* 85.91±1.96*
Group III Rivastigmine (0.3 mg/kg) 96.82±1.07$ 82.08±3.30$
Group IV A.O (200 mg/kg) 123.0±0.98$a 110.8±1.66$a
Group V A.O (400 mg/kg) 157.5±4.61$ 122.0±4.29$
Values were expressed as Mean±SEM of each group (n=6) and were significant 
when done One-way ANOVA with Tukey’s post hoc test. *p<0.001 when 
compared with normal, $p<0.001 with positive control, ap<0.001 with the 
standard, SEM: Standard error mean
Table 3: Estimation of AchE activity
Groups Treatment AchE activity  
(OD value/mg protein)
Group I Vehicle only 0.34±0.003
Group II Alcl3 (100 mg/kg) 0.04±0.02*
Group III Rivastigmine (0.3 mg/kg) 0.21±0.004$
Group IV A.O (200 mg/kg) 0.13±0.02$a
Group V A.O (400 mg/kg) 0.24±0.01$
AchE: Acetyl cholinesterase, $p<0.001 with positive control, ap<0.001 with 
standard, *p<0.001 when compared with normal
Table 6: Estimation of SOD
Groups Treatment SOD, units/mg protein
Group I Vehicle only 93.7±0.013
Group II Alcl3 (100 mg/kg) 26.5±0.021*
Group III Rivastigmine (0.3 mg/kg) 91.0±0.066$
Group IV A.O (200 mg/kg) 82.6±0.023$a
Group V A.O (400 mg/kg) 91.8±0.042$c
SOD: Super oxide dismutase, $p<0.001 with positive control, ap<0.001 with 
standard, *p<0.001 when compared with normal, cp<0.001 with Negative control.
Table 5: Estimation of lipid peroxidation MDA
Groups Treatment nmole MDA/mg protein
Group I Vehicle only 110.69 ± 0.014
Group II Alcl3 (100 mg/kg) 222.40 ± 0.018*
Group III Rivastigmine (0.3 mg/kg) 111.72 ± 0.020$
Group IV A.O (200 mg/kg) 150.2 ± 0.012$a
Group V A.O (400 mg/kg) 115.4 ± 0.019$c
MDA: Malondialdehyde, $p<0.001 with positive control, ap<0.001 with standard, 
*p<0.001 when compared with normal, cp<0.001 with Negative control.
Table 4: Estimation of total protein
Groups Treatment Protein activity mg/g
Group I Vehicle only 6.65±0.07
Group II Alcl3 (100 mg/kg) 11.46±0.13*
Group III Rivastigmine (0.3 mg/kg) 7.65±0.07$
Group IV A.O (200 mg/kg) 8.68±0.06$a
Group V A.O (400 mg/kg) 8.05±0.09$c
$p<0.001 with positive control, ap<0.001 with standard, *p<0.001 when 
compared with normal
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For estimation of lipid peroxidation MDA
Table 5 and Figure 5 reveals the % increment of lipid peroxidase 
observed in A.O (400 mg/kg) dose as compared with that of standard 
drug was found to be 96.8%.
For estimation of SOD
Table 6 and Figure 6 reveals the % reduction of SOD observed in A.O 
(400 mg/kg) dose as compared with that of standard drug was found 
to be 99%.
For estimation of catalase
Table 7 and Figure 7 reveals the % reduction of catalase observed in A.O 
(400 mg/kg) dose as compared with that of standard drug was found 
to be 97%.
For estimation of GR
Table 8 and Figure 8 reveals the % reduction of GR observed in A.O 
(400 mg/kg) dose as compared with that of standard drug was found 
to be 89%.
Histopathological results of brain
After sacrifice of all the animals, their brains were dissected out and 
fixed in 10% neutral formalin. The tissues were processed in the 
usual way for paraffin embedding and sections were mainly stained 
with Hematoxylin and Eosin for histopathology (20x) studies. From 
the Figure 9, the section of brain of normal rat’s revealed presence of 
plaque and neurofibrillary tangles with cell degeneration, while from 
the figure 10, those groups treated with rivastigmine showed cell 
restoration similar to normal control group.
DISCUSSION
In the present study, the neuroprotective effect of alcoholic 
A. occidentale extract was investigated in aluminum chloride [13] 
induced Alzheimer’s disease. Since aluminum chloride induced 
Alzheimer’s diseasegenerally preferred appropriate model for the 
early onset of senile dementia, we used the above model for disease 
induction [14]. The extract used proved to have neuroprotection as 
an evidence of improvement in the neurological score of AchE, lipid 
peroxidation, glutathione, catalase, GR, SOD, protein. The purified and 
dried yield of alcoholic A. occidentale extract was subjected for the 
acute toxicity study to determine the therapeutic dose using albino rats 
in a controlled environment. Acute toxicity studies were performed 
according to the OECD 423 guidelines. The extract was administered 
through oral route to different groups of rats using oral feeding 
needle (22 gauge). No deviation from normal behavioral pattern was 
observed. The observation was done continuously for 14 days, and 
mortality was not observed in any of the drug-treated group; hence, 
it was confirmed that the test drug alcoholic A. occidentale extract 
is practically nontoxic in normal rats and fall under the category 
of class V drugs, according to OECD guidelines. 1/10th of dose was 
considered therapeutic dose and to identify the dose-dependent 
action the 200% of therapeutic dose was considered maximum dose 
for further pharmacological evaluation in animal model. Lower dose 
(200 mg/kg) and higher dose (400 mg/kg).
Fig. 5: Estimation of lipid peroxidation malondialdehyde
Fig. 6: Estimation of super oxide dismutase
Fig. 7: Estimation of catalase
Fig.8: Estimation of glutathione reductase 
Table 8: Estimation of GR
Groups Treatment mole GSH/mg protein
Group I Vehicle only 42.84±0.47
Group II Alcl3 (100 mg/kg) 23.93±0.83*
Group III Rivastigmine (0.3 mg/kg) 38.80±0.024$
Group IV A.O (200 mg/kg) 27.78±0.66$a
Group V A.O (400 mg/kg) 34.82±0.64$c
GR: Glutathione reductase, $p<0.001 with positive control, ap<0.001 with 
standard, *p<0.001 when compared with normal, cp<0.001 with Negative control.
Table 7: Estimation of catalase
Groups Treatment Catalase µmol  
H2O2/minute/mg protein
Group I Vehicle only 97.3±0.351
Group II Alcl3 (100 mg/kg) 25.05±0.01*
Group III Rivastigmine (0.3 mg/kg) 89.7±0.059$
Group IV A.O (200 mg/kg) 74.9±0.088$a
Group V A.O (400 mg/kg) 91.9±0.063$c
$p<0.001 with positive control, ap<0.001 with standard, *p<0.001 when 
compared with normal, cp<0.001 with Negative control.
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Higher doses of alcoholic A. occidentale extract 400 mg/kg elicited 
neuroprotective activity when compared to lower dose 200 mg/kg. 
This may be attributed to the presence of flavonoids, alkaloids, steroids, 
tannins, and minerals of A. occidentale fruit. Free radicals have 
been implicated in Alzheimer’s and reperfusion-induced neuronal 
injury [15]. Free radicals promote lipid peroxidation [16] which 
results in the alteration in permeability and fluidity of the membrane. 
Reactive oxygen species (ROS) produces MDA, an end product of lipid 
peroxidation. MDA reacts with thiobarbituric acid and is thus estimated 
as thiobarbituric acid reactive substances (TBARS). Therefore, in the 
present study MDA was estimated using TBARS assay to estimate the 
extent of ROS formation. It is well reported that overproduced free 
radicals are detoxified by endogenous antioxidants. Glutathione is 
considered a central component in the antioxidant defenses of cells. 
It acts both to directly detoxify ROS and as a substrate for various 
peroxidises [17]. Aluminum is a potent choline toxin where it gains 
high affinity to transferrin expressed in the blood–brain barrier. On 
entering the brain, it induces inflammatory responses, slows down 
axonal transport, inhibits long-term potentiation, and causes structural 
abnormalities, thereby causing a decrease in the levels of acetylcholine 
at the synaptic cleft [18]. The results of this study indicate that 
chronic administration of aluminum chloride results in progressive 
deterioration of spatial memory and motor in coordination elicited 
through behavioral parametric estimations in elevated plus maze and 
Rota-rod paradigms.
In the elevated plus maze, on the 20th day the ITL was taken and 
there was no significant variation. Normal control (*p<0.001) and 
A. occidentale extract-treated (200 mg/kg) and (400 mg/kg) rats 
entered closed arm quickly and the mean retention latencies (1st RTL 
and 2nd RTL) to enter the closed arms on days 21 and 42 were shorter 
when compared to ITL. Aluminum chloride-treated ($p<0.001) rats 
showed no variation in mean retention latency on the 21st and 42nd day 
when compared to pre-trained animals ITL on the 20th day. This shows 
cognitive impairment of aluminum chloride-treated animals. In Rota-
rod apparatus, the fall off time is being recorded for each group of 
animal and is known to observe on the 20th day as initial fall off time. 
Standard (ap<0.001) A. occidentale extract (200 mg/kg and 400 mg/
kg) showed decrease in fall off time on the 21st day and 42nd day after 
training. Positive control ($p<0.001) showed an increase in fall of time 
when compared to initial fall off time. This shows neurological deficit 
elicits motor in coordination.
In this study, chronic administration of aluminum chloride resulted in 
marked oxidative stress as indicated by increase in lipid peroxidation, 
decrease in reduced glutathione levels, catalase, and superoxide 
dismutase and glutathione- S-transferase activity in the positive control 
group animals. This could be due to the reduced axonal mitochondria 
turnover, disruption of Golgi and reduction of synaptic vesicles induced 
by aluminum treatment which results in release of oxidative products 
such as MDA, carbonyls, peroxynitrites and enzymes like superoxide 
dismutase within the neurons [19].
In the present study, alcoholic extract of A. occidentale fruit resulted in an 
increase in acetylcholine levels and its anti-oxidants proved to scavenge 
free radicals and helped in treating the disease. Chronic administration 
of alcoholic A. occidentale extract (200 mg/kg) and (400 mg/kg) proved 
a marked increase in level of acetylcholine compared to the positive 
control ($p<0.001). Aluminum chloride-administered rats showed a 
great decline in acetylcholine levels when compared to normal control 
(*p<0.001). This proves that the A. occidentale fruit extract showed 
evidence for neuroprotection.
Aluminum chloride induced (positive control) rats showed a 
significant increase in aluminum in the cortex of the brain when 
compared to normal control (*p<0.05), standard and A. occidentale 
extract (200 mg/kg) ($ap<0.05)-treated rats. Chronic administration 
of aluminum chloride showed a marked increase in free radical 
generation and increase in MDA levels, causing lipid peroxidation when 
compared to normal control (*p<0.001) and treatment with alcoholic 
A. occidentale extract (200 mg/kg) and (400 mg/kg) showed decrease in 
levels of MDA compared to the positive control ($p<0.001). Rivastigmine 
was used as a standard drug as it the only proven pharmacological 
therapy for symptomatic treatment of AD [20]. Treatment of AD rats 
with rivastigmine as a protective agent led to an improvement in the 
oxidative stress as represented by a significant increase in acetylcholine 
levels as well as improving results in behavioral and biochemical 
parameters when compared with AD induced diseased rats. Aluminum 
leads to oxidative stress which caused a decrease in antioxidants 
SOD, glutathione, catalase, glutathione, and GR in the positive control. 
Treatment with alcoholic A. occidentale extract (200 mg/kg) and 
(400 mg/kg) showed an increase in the levels of the antioxidants as 
shown in respectively, when compared to a positive control ($p<0.001).
Rivastigmine and test drug (A. occidentale fruit extract) showed results 
that were confirmed by the histopathological findings of brain tissues, 
wherein amyloid plaques that are formed from AlCl3 administration 
disappeared in treated rats when compared to disease rats. The 
Fig. 9: Histopathology results of the brain, (a) Image of the 
brain section of a normal control rats (Group I) showing normal 
histological structure of the hippocampus, (b) Image of brain 
section of positive controlled group (Group II) showing plaque in 
hippocampus, (c) Section of brain of rats given Alcl3 without any 
treatment showing neurofibrillary tangles
Fig. 10: (a) A section of brain of rat treated with rivastigmine 
(0.3 mg/kg) + Alcl3 for 20 days as a protection against AD, 
showing neurons i.e., more or less like normal group, (b) Section 
of brain treated with Alcl3 + 200 mg/kg of A. occidentale extract 
for 42 days as a protection against AD, showing neurons, i.e., 
more or less like normal group, (c) Section of brain treated 
with Alcl3 + 400 mg/kg of A. occidentale extract for 42 days as a 
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efficacy of rivastigmine in the treatment of dementia, where it binds 
to AchE molecule in the precursor if Ach in an irreversible manner. 
A. occidentale fruit extract also inhibits amyloid formation by directly 
inhibiting Aβ aggregation, metal chelation, antioxidant property, 
hypocholesterolemic effect, modulating-secretase activity, anti-
inflammatory property and modulating the JNK signaling pathways. 
All these effects may also contribute to its neuroprotective effect. 
This also explains the fact that aluminum chloride treatment caused 
a marked reduction in the acetylcholinesterase activity which was 
restored by chronic papaya leaf treatment. Our results also support 
that A. occidentale extract decreased the concentration of aluminum 
in hippocampus particularly. The hippocampus and dentate gyrus of 
the brain are mainly responsible for memory formation. This could 
be the only mechanistic pathways for the neuroprotective effect of 
A. occidentale fruit in cognitive dysfunction of aluminum-treated rats. 
From the epidemiologic and experimental studies reported, there is 
ample evidence which supports the fact that aluminum plays a pivotal 
role in the neuropathology of AD.
This study validates the fact that chronic exposure to aluminum 
causes cognitive dysfunction and related oxidative damage. It clearly 
demonstrates that A. occidentale fruit has a neuroprotective effect 
against aluminum-induced behavioral and biochemical changes 
and further warrants the need for molecular studies to elucidate 
the mechanisms underlying the protective effects of A. occidentale. 
From the acute toxicity study, it was concluded that the test drug 
A. occidentale is practically non-toxic on oral administration. 
A number of models have been used for the study of Alzheimer’s 
disease. In the present study of aluminum chloride administration 
proved synergistic effects on accelerating the development and 
progression of Alzheimer’s disease. Long-term oral administration of 
aluminum chloride for 42 days caused Alzheimer’s disease in rodent 
model which involves the pathological, neurochemical, behavioral, 
and biochemical alterations in the levels of acetylcholinesterase 
activity, protein, catalase, SOD, MDA, GH. Pre-treatment with A. 
occidentale significantly reverted the Alcl3 induced changes in rats. The 
constituents of A. occidentale has volatile compounds - resorcinolic 
acid, anacardic acids, carotenoids, vitamin C, phenols, and tannin and 
phenolic constituents - anacardic acids, cardols, cardanols having a 
powerful anti-oxidant activity. The presence of the above constituents 
might be responsible for neuroprotective effect of A. occidentale 
against Alcl3 induced in rats.
The present study indicates the cumulative protective effect of 
A. occidentale with the high level of antioxidant activity against AlCl3 
induced spatial memory deficit and further confirms the beneficial 
effect of antioxidants in neurodegenerative disorder such as AD. Thus, 
it might be concluded that A. occidentale, through its antioxidant 
potential, provided neuroprotection against AlCl3 induced cognitive 
deficits and oxidative damage in rats. A preventive measure addressing 
the cognitive decline can be expected to have a therapeutic influence 
on the aging population by reducing the well-recognized prevalence of 
Alzheimer’s disease. The A. occidentale treatment showed improvement 
in memory. Further investigation into the role and mechanisms of 
antioxidant action are needed to be determined which can be an 
effective remedy for Alzheimer’s disease. This study reveals that A. 
occidentale, as a powerful antioxidant for treating cognitive deficits, 
oxidative damage [21], and morphological changes in the diseased 
rats. Thus, it may have a good therapeutic value for the treatment of 
Alzheimer’s disease.
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